Some publications from ABPI and other organisations are available to download; these include research reports and other publications.
This report from the ABPI finds that the UK’s traditional strength in science is eroding, science graduates are lacking practical skills useful to industrial research and that urgent action by a range of partners is required to arrest this decline.
The study, the result of a six-month analysis by the ABPI Science, Technology, Engineering and Manufacturing (STEM) Education & Skills Taskforce, recognised Government commitment to science, but hlighted particular shortages in chemistry, clinical pharmacology and in vivo biology.
The skills pipeline in the UK is increasingly recognised to be in decline in many sectors and especially in those that supply scientifically qualified entrants to companies engaged in research and development (R&D). Across the UK there are many taskforces and work groups being set up to identify the key issues in the provision of skills and to put measures in place to address them. For Pfizer as a major employer in South East England in the R&D and manufacturing sectors, the aims of this report were fourfold:
• To raise awareness of the types of skills needed in pharmaceutical R&D,
• To survey the specific reasons for skills-related recruitment difficulties across the UK R&D and manufacturing divisions,
• To quantify the current activities being undertaken by Pfizer to address them,
• To provide suggestions to education providers that could enhance the number and quality of scientifically skilled entrants to address them.
In countries across the world, millions of people are dying unnecessarily each year from diseases that can easily be prevented or effectively treated. This booklet explains the pharmaceutical industry's approach to some of the complicated issues surrounding world health. It demonstrates the work that companies are undertaking to improve health in poor nations and looks ahead to what more may be done in the future.
A briefing paper on the topic of the development of medicines.
A briefing paper on the topic of clinical trials.